TMED8
gene geneOn this page
Summary
TMED8 (transmembrane p24 trafficking protein family member 8, HGNC:18633) is a protein-coding gene on chromosome 14q24.3, encoding Protein TMED8 (Q6PL24).
At a glance
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_213601
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18633 |
| Approved symbol | TMED8 |
| Name | transmembrane p24 trafficking protein family member 8 |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000100580 |
| Ensembl biotype | protein_coding |
| Entrez | 283578 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000216468, ENST00000868372
RefSeq mRNA: 4 — MANE Select: NM_213601
NM_001346131, NM_001346133, NM_001346134, NM_213601
CCDS: CCDS32125
Canonical transcript exons
ENST00000216468 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000659299 | 77343178 | 77343483 |
| ENSE00000659300 | 77343697 | 77343823 |
| ENSE00000659301 | 77346349 | 77346478 |
| ENSE00001231307 | 77351673 | 77351751 |
| ENSE00001231314 | 77376936 | 77377094 |
| ENSE00001231326 | 77335029 | 77341988 |
Expression profiles
Bgee: expression breadth ubiquitous, 259 present calls, max score 99.10.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.1169 / max 238.3430, expressed in 1810 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144225 | 19.6724 | 1809 |
| 144226 | 0.2723 | 134 |
| 207311 | 0.1723 | 49 |
Top tissues by expression
261 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 99.10 | gold quality |
| secondary oocyte | CL:0000655 | 98.48 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 98.44 | gold quality |
| pancreatic ductal cell | CL:0002079 | 98.33 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 98.18 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 97.79 | gold quality |
| oviduct epithelium | UBERON:0004804 | 97.10 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.32 | gold quality |
| oocyte | CL:0000023 | 96.00 | gold quality |
| tibia | UBERON:0000979 | 95.46 | gold quality |
| ileal mucosa | UBERON:0000331 | 95.33 | gold quality |
| visceral pleura | UBERON:0002401 | 94.68 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 94.20 | gold quality |
| parietal pleura | UBERON:0002400 | 94.10 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 93.87 | gold quality |
| entorhinal cortex | UBERON:0002728 | 93.13 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 92.96 | gold quality |
| parietal lobe | UBERON:0001872 | 92.82 | gold quality |
| postcentral gyrus | UBERON:0002581 | 92.81 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 92.63 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 92.37 | gold quality |
| medulla oblongata | UBERON:0001896 | 92.13 | gold quality |
| caput epididymis | UBERON:0004358 | 92.04 | gold quality |
| renal medulla | UBERON:0000362 | 92.01 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.98 | gold quality |
| nasopharynx | UBERON:0001728 | 91.96 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 91.96 | gold quality |
| cauda epididymis | UBERON:0004360 | 91.87 | gold quality |
| ventral tegmental area | UBERON:0002691 | 91.86 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 91.49 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | yes | 10.89 |
| E-ANND-3 | yes | 5.86 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmed8 | ENSDARG00000052390 |
| mus_musculus | Tmed8 | ENSMUSG00000034111 |
| rattus_norvegicus | Tmed8 | ENSRNOG00000077115 |
| drosophila_melanogaster | CG14232 | FBGN0031061 |
| caenorhabditis_elegans | WBGENE00012765 |
Paralogs (1): ACBD3 (ENSG00000182827)
Protein
Protein identifiers
Protein TMED8 — Q6PL24 (reviewed: Q6PL24)
All UniProt accessions (1): Q6PL24
RefSeq proteins (4): NP_001333060, NP_001333062, NP_001333063, NP_998766* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009038 | GOLD_dom | Domain |
| IPR036598 | GOLD_dom_sf | Homologous_superfamily |
| IPR052269 | Golgi-PI4KB_interaction | Family |
Pfam: PF13897
UniProt features (7 total): region of interest 2, chain 1, domain 1, compositionally biased region 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PL24-F1 | 69.91 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 169
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 72 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, chr14q24, DOUGLAS_BMI1_TARGETS_DN, SENESE_HDAC3_TARGETS_DN, DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP, DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP, FORTSCHEGGER_PHF8_TARGETS_DN, ELF2_TARGET_GENES, ZMYM2_TARGET_GENES, ZNF563_TARGET_GENES, ZNF711_TARGET_GENES, GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN, GSE14000_UNSTIM_VS_4H_LPS_DC_UP, GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
1023 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMED8 | SAMD15 | Q9P1V8 | 599 |
| TMED8 | NOXRED1 | Q6NXP6 | 575 |
| TMED8 | SLIRP-OT1 | Q8N769 | 574 |
| TMED8 | OR10C1 | Q96KK4 | 419 |
| TMED8 | GSTZ1 | O43708 | 414 |
| TMED8 | TMEM63C | Q9P1W3 | 409 |
| TMED8 | OR52K1 | Q8NGK4 | 399 |
| TMED8 | SHISAL2B | A6NKW6 | 392 |
| TMED8 | PUS7L | Q9H0K6 | 387 |
| TMED8 | DEPDC7 | Q96QD5 | 381 |
| TMED8 | DNLZ | Q5SXM8 | 377 |
| TMED8 | ZNF280D | Q6N043 | 371 |
| TMED8 | ARL6IP6 | Q8N6S5 | 371 |
| TMED8 | FAM153A | Q9UHL3 | 370 |
| TMED8 | LGSN | Q5TDP6 | 367 |
IntAct
136 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| TMED8 | STX8 | psi-mi:“MI:0915”(physical association) | 0.600 |
| TMED8 | DEFB129 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MRPL41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | EI24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | CMTM5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAPTM4A | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | CIAO2A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARL6IP1 | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | SERP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM218 | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | APOL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UNC50 | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | DGAT2L6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | TMEM254 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | CYB561D1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | C10orf67 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | TRAM1L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MMGT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | ADTRP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MRPS18B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (95): TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Affinity Capture-MS), TMED8 (Proximity Label-MS), TMED8 (Proximity Label-MS), TMED8 (Proximity Label-MS), TMED8 (Two-hybrid), TMED8 (Two-hybrid)
ESM2 similar proteins: A0JPN4, A2ARK0, A4QP72, A6ND36, A6QQJ8, D3ZD05, E9Q0S6, O14529, O70240, O88566, P59281, P70298, Q148V8, Q1LZH7, Q3UHI4, Q3UIL6, Q5D1E7, Q5D1E8, Q5DU25, Q5JU85, Q5JV73, Q5R8S0, Q5R9S0, Q5SWY7, Q5XK72, Q63ZY3, Q68CZ2, Q6IQ23, Q6P1H6, Q6P9J5, Q6PDH0, Q6PL24, Q7TNY7, Q7TP65, Q7TSG2, Q80Y50, Q86UU1, Q86UY5, Q86XL3, Q8BX02
Diamond homologs: Q3UHI4, Q5R9S0, Q6PL24, Q7TNY6, Q8BMP6, Q9H3P7, A0FKI7, P07106, Q2KHT9, Q4V869, Q5R7P6, Q5R7V3, Q5T8D3, Q5XG73, Q5ZHQ6, Q640U0, Q641E3, Q66JD7, Q6DGF9, Q8NC06, Q8R0F9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1433 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:77341767:T:TA | donor_gain | 1.0000 |
| 14:77343173:TTTAC:T | donor_loss | 1.0000 |
| 14:77343174:TTAC:T | donor_loss | 1.0000 |
| 14:77343175:TAC:T | donor_loss | 1.0000 |
| 14:77343177:C:T | donor_loss | 1.0000 |
| 14:77343189:T:TA | donor_gain | 1.0000 |
| 14:77343484:C:CC | acceptor_gain | 1.0000 |
| 14:77346483:C:CT | acceptor_gain | 1.0000 |
| 14:77346484:A:T | acceptor_gain | 1.0000 |
| 14:77351668:GTTAC:G | donor_loss | 1.0000 |
| 14:77351669:TTAC:T | donor_loss | 1.0000 |
| 14:77351670:TACC:T | donor_loss | 1.0000 |
| 14:77351672:CC:C | donor_loss | 1.0000 |
| 14:77351749:TCTCT:T | acceptor_loss | 1.0000 |
| 14:77351750:CT:C | acceptor_gain | 1.0000 |
| 14:77351751:TC:T | acceptor_loss | 1.0000 |
| 14:77351752:C:CC | acceptor_gain | 1.0000 |
| 14:77351753:T:A | acceptor_loss | 1.0000 |
| 14:77351760:CCA:C | acceptor_gain | 1.0000 |
| 14:77351761:C:CT | acceptor_gain | 1.0000 |
| 14:77351762:A:C | acceptor_gain | 1.0000 |
| 14:77376932:GTACC:G | donor_loss | 1.0000 |
| 14:77376933:TACC:T | donor_loss | 1.0000 |
| 14:77376934:A:AG | donor_loss | 1.0000 |
| 14:77376935:CCTG:C | donor_loss | 1.0000 |
| 14:77376965:C:CA | donor_gain | 1.0000 |
| 14:77341774:G:C | donor_gain | 0.9900 |
| 14:77343176:A:AC | donor_gain | 0.9900 |
| 14:77343177:C:CC | donor_gain | 0.9900 |
| 14:77343177:CCTT:C | donor_gain | 0.9900 |
AlphaMissense
2130 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:77341804:C:A | K315N | 1.000 |
| 14:77341804:C:G | K315N | 1.000 |
| 14:77341828:G:C | N307K | 1.000 |
| 14:77341828:G:T | N307K | 1.000 |
| 14:77341835:A:G | F305S | 1.000 |
| 14:77341844:A:G | L302P | 1.000 |
| 14:77343275:A:C | F221L | 1.000 |
| 14:77343275:A:T | F221L | 1.000 |
| 14:77343276:A:G | F221S | 1.000 |
| 14:77343277:A:G | F221L | 1.000 |
| 14:77343285:C:T | G218E | 1.000 |
| 14:77343287:A:C | F217L | 1.000 |
| 14:77343287:A:T | F217L | 1.000 |
| 14:77343289:A:G | F217L | 1.000 |
| 14:77343314:A:C | F208L | 1.000 |
| 14:77343314:A:T | F208L | 1.000 |
| 14:77343315:A:G | F208S | 1.000 |
| 14:77343316:A:G | F208L | 1.000 |
| 14:77343320:C:A | W206C | 1.000 |
| 14:77343320:C:G | W206C | 1.000 |
| 14:77343322:A:G | W206R | 1.000 |
| 14:77343322:A:T | W206R | 1.000 |
| 14:77341805:T:A | K315M | 0.999 |
| 14:77341806:T:C | K315E | 0.999 |
| 14:77341806:T:G | K315Q | 0.999 |
| 14:77341812:G:T | R313S | 0.999 |
| 14:77341821:A:G | S310P | 0.999 |
| 14:77341824:A:C | Y309D | 0.999 |
| 14:77341827:A:G | S308P | 0.999 |
| 14:77341829:T:A | N307I | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000026777 (14:77355147 A>G), RS1000092607 (14:77348002 C>A,T), RS1000311493 (14:77345498 C>A,T), RS1000423278 (14:77347611 G>A), RS1000536753 (14:77352828 G>A), RS1000667890 (14:77359571 A>T), RS1000891701 (14:77334714 G>A), RS1001029518 (14:77353430 C>A,G,T), RS1001030506 (14:77346113 C>T), RS1001236820 (14:77365848 T>C), RS1001248750 (14:77342311 A>G), RS1001277366 (14:77369785 C>G), RS1001302259 (14:77360610 G>A), RS1001328351 (14:77369983 C>T), RS1001396209 (14:77366372 CACCTG>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Phenylmercuric Acetate | decreases expression, affects cotreatment | 2 |
| Valproic Acid | increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| afimoxifene | decreases reaction, increases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Coumestrol | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Estrogens | decreases reaction, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Progesterone | increases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.